(1/5) The National Advisory Committee on Immunization (NACI) strongly recommends a Pfizer #Covid19 booster be offered to high risk children 5-11 at least 6 months after completion of a primary series or having COVID-19. More: https://t.co/Idq1MDGO2t pic.twitter.com/h7f9qRQ3ID
— Health Canada and PHAC (@GovCanHealth) August 19, 2022
Health Canada Approves Pfizer Booster For Children Aged 5-11
